Redmont Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$54.8K Hold
51
0.08% 91
2025
Q3
$38.9K Hold
51
0.05% 113
2025
Q2
$39.8K Buy
+51
New +$39.6K 0.06% 109
2024
Q4
Sell
-51
Closed -$45.2K 193
2024
Q3
$45.2K Hold
51
0.07% 95
2024
Q2
$46.2K Hold
51
0.07% 90
2024
Q1
$39.7K Buy
+51
New +$36.3K 0.06% 105
2023
Q1
Sell
-3,001
Closed -$1.1M 97
2022
Q4
$1.1M Hold
3,001
1.29% 12
2022
Q3
$970K Buy
3,001
+1
+0% +$317 1.26% 13
2022
Q2
$973K Hold
3,000
1.18% 16
2022
Q1
$859K Hold
3,000
0.91% 22
2021
Q4
$829K Buy
+3,000
New +$761K 0.89% 27

Other funds holding LLY

Redmont Wealth Advisors's LLY Position: Q4 2025 in Review

Redmont Wealth Advisors held its Eli Lilly (LLY) position steady in Q4 2025 at 51 shares worth $54.8K. The position accounts for 0.08% of the portfolio, ranked #91.

Redmont Wealth Advisors first reported a position in LLY in Q4 2021 and has held it in 11 quarters since. The position peaked at $1.1M in Q4 2022. 4,441 funds tracked by Wall St. Rank hold LLY as of Q4 2025.

  • Redmont Wealth Advisors held 51 shares of Eli Lilly worth $54.8K as of Q4 2025.
  • Redmont Wealth Advisors left its Eli Lilly share count unchanged in Q4 2025.
  • Eli Lilly made up 0.08% of Redmont Wealth Advisors's portfolio in Q4 2025, its #91 holding.
  • Redmont Wealth Advisors first reported a position in Eli Lilly in Q4 2021 and has held it in 11 quarters since.
  • Redmont Wealth Advisors's Eli Lilly position peaked at $1.1M in Q4 2022.
  • 4,441 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2025.

Based on Redmont Wealth Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.